Sponsors & Supporters
The organisers of the 9th Annual Scientific Meeting of the Singapore Sociology of Oncology (SSO ASM 2024) would like to thank the following sponsors and supporters for their contributions to the meeting.
Diamond Sponsor
Novartis (Singapore) Pte Ltd
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Platinum Sponsor
MSD Pharma (Singapore) Pte Ltd
At MSD, known as Merck &Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable, and healthy future for all people and communities.
Daiichi Sankyo Singapore Pte Ltd
Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich the quality of life around the world. With more than 125 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer and other diseases with high unmet medical needs.
Gold Sponsor
Pfizer Pte Ltd
At Pfizer, we apply science to bring innovative medicines and vaccines to improve patient lives. Consistent with our responsibility, we collaborate with health care providers, governments, and local communities to improve and expand access. For 175 years, we have worked to make a difference for all who rely on us.
Pierre Fabre Singapore Pte Ltd
Pierre Fabre Laboratories, a leading French medical and beauty care company, focuses on oncology with 80% of R&D dedicated to this field. Generating 2.83 billion euros in 2023, 70% from international sales, the company operates in 120 countries. It is 86%-owned by the Pierre Fabre Foundation and emphasizes sustainability.
Roche Singapore Pte Ltd
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals, diagnostics and leveraging data at scale. We are committed to applying our expertise in breast, lung and blood cancers to develop new innovations that deliver better outcomes, transform standards of care and maximise the chance of cure.
Bronze Sponsor
Astellas Pharma Singapore Pte Ltd
Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality.
BeiGene Singapore Pte Ltd
BeiGene is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 10,000 colleagues spans five continents.
Supporters
AstraZeneca Singapore Pte Ltd
We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
Bristol-Myers Squibb (Singapore) Pte Ltd
Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases.
Each day, our employees around the world work together for patients – it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, hematology, cardiovascular, immunoscience and fibrosis. Through our R&D organization, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.
As global citizens, we work sustainably, responsibly and seek to give back. Through the Bristol-Myers Squibb Foundation, we promote health equity and strive to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.
DKSH Singapore Pte Ltd
DKSH Singapore is the leading Market Expansion Services provider for companies who want to grow their business in Singapore.
We offer our business partners tailor-made solutions along the entire value chain to support them in achieving their objectives. Our business partners leverage DKSH’s capillary distribution network, deep local market expertise, and extensive supply chain network to expand and grow their businesses.
Fresenius Kabi (Singapore) Pte Ltd
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products are used to help care for critically and chronically ill patients. Our portfolio comprises of I.V. generic drugs, infusion therapies, clinical nutrition, and devices for administering these products.
Gilead Sciences Singapore Pte Ltd
Gilead and Kite Oncology are creating the future of oncology. From ADCs and small molecules to cell therapy, our R&D programs and partnerships are focused on helping to bring more life to people with cancer and changing the way cancer is treated.
GlaxoSmithKline Pte Ltd
Johnson & Johnson International (Singapore) Pte Ltd
In Johnson & Johnson, patients inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science and compassion, we confidently address some of the most complex diseases of our time and unlock the potential medicines of tomorrow.
Juniper Biologics Pte Ltd
Juniper Biologics is a science-led healthcare company focused on Researching, Developing & Commercialising novel therapies. It was founded on a vision to provide the next generation of life-changing treatments for unmet needs focused on specialist therapy areas in which it can make the most difference.
Juniper Biologics is headquartered in Singapore with commercial operations in China, Japan, Asia, Australia & New Zealand, Middle East & Africa. Juniper Biologics specialises in a portfolio of drugs in Oncology and Oncology Supportive care, Rare Diseases, and Gene Therapy.
Takeda Pharmaceuticals (Asia Pacific) Pte Ltd
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 240 years of distinguished history in Japan.
We have presence in approximately 80 countries, with leading positions in Japan and the U.S., respectively the third and first largest pharmaceutical markets in the world. We will deliver highly innovative medicines and transformative care for more people globally.
For more than 230 years, Takeda has developed its business with integrity while undergoing a process of continuous transformation.
Takeda began operations in 1781 when Chobei Takeda I started a business selling traditional Japanese and Chinese medicines in Doshomachi, Osaka. Takeda has been supplying pharmaceuticals for over 230 years, during which time we have developed a strong commitment to the highest ethical standards and a strong sense of mission. We have made constant efforts to improve our relationship with society over this time. As we move forward, we will continue to fulfil our responsibilities as a global Biopharmaceutical company.
Takeda Pharmaceuticals (Asia Pacific) Pte Ltd
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 240 years of distinguished history in Japan.
We have presence in approximately 80 countries, with leading positions in Japan and the U.S., respectively the third and first largest pharmaceutical markets in the world. We will deliver highly innovative medicines and transformative care for more people globally.
For more than 230 years, Takeda has developed its business with integrity while undergoing a process of continuous transformation.
Takeda began operations in 1781 when Chobei Takeda I started a business selling traditional Japanese and Chinese medicines in Doshomachi, Osaka. Takeda has been supplying pharmaceuticals for over 230 years, during which time we have developed a strong commitment to the highest ethical standards and a strong sense of mission. We have made constant efforts to improve our relationship with society over this time. As we move forward, we will continue to fulfil our responsibilities as a global Biopharmaceutical company.
Zuellig Pharma Pte Ltd
ZP Therapeutics is a valued partner for healthcare commercialisation, innovation, and expanding patient access across the region. As a trusted healthcare partner, our commercial excellence, in-market capabilities, ethical principles and values are driven by our commitment to improving patient journeys and healthcare outcomes.
Fresenius Kabi (Singapore) Pte Ltd
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products are used to help care for critically and chronically ill patients. Our portfolio comprises of I.V. generic drugs, infusion therapies, clinical nutrition, and devices for administering these products.